Dr. Puri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4809 Ambassador Caffery Pkwy
Ste 230
Lafayette, LA 70508Phone+1 337-470-2739Fax+1 337-235-7891
Education & Training
- Dayanand Medical College Class of 2013
Certifications & Licensure
- TX State Medical License 2024 - 2026
- LA State Medical License 2021 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- NOS inhibition sensitizes metaplastic breast cancer to PI3K inhibition and taxane therapy via c-JUN repression.Tejaswini Reddy, Akshjot Puri, Liliana Guzman-Rojas, Christoforos Thomas, Wei Qian
Nature Communications. 2024-12-30 - 2 citationsClinical factors and association with treatment modalities in patients with breast cancer and brain metastases who develop leptomeningeal metastases.Akshjot Puri, Charisma Mylavarapu, Jiaqiong Xu, Tejal A Patel, Bin S Teh
Breast Cancer Research and Treatment. 2022-06-01 - 4 citationsSkeletal metastases in advanced pancreatic ductal adenocarcinoma: a retrospective analysis.Akshjot Puri, John Chang, Natalee Tanner, Patricia Lucente, Janice Desiongco
Journal of Gastrointestinal Oncology. 2021-04-01
Press Mentions
- Houston Methodist Researchers Pioneer New Treatment Strategies for Metaplastic Breast CancerJanuary 22nd, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: